Clinical Trial Update: A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating BMS-986458 alone and in combination with anti-lymphoma agents for relapsed or refractory Non-Hodgkin lymphoma; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• BMS-986458

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Relapsed/Refractory Non-Hodgkin Lymphoma | Phase 1, Phase 2 | Status: RECRUITING